7.05 USD
-0.02 (-0.28%)
6.93 USD
-0.12 (-1.7%)
KMDA gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 530 industry peers in the Biotechnology industry. While KMDA has a great profitability rating, there are some minor concerns on its financial health. KMDA is valued quite cheap, while showing a decent growth score. This is a good combination! This makes KMDA very considerable for value investing!
1. Profitability
1.1 Basic Checks
In the past year KMDA was profitable.
In the past year KMDA had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: KMDA reported negative net income in multiple years.
KMDA had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
KMDA has a Return On Assets of 5.42%. This is amongst the best in the industry. KMDA outperforms 91.70% of its industry peers.
Looking at the Return On Equity, with a value of 7.72%, KMDA belongs to the top of the industry, outperforming 91.51% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 6.67%, KMDA belongs to the top of the industry, outperforming 92.83% of the companies in the same industry.
KMDA had an Average Return On Invested Capital over the past 3 years of 2.97%. This is significantly below the industry average of 18.22%.
The last Return On Invested Capital (6.67%) for KMDA is above the 3 year average (2.97%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.42% | ||
| ROE | 7.72% | ||
| ROIC | 6.67% |
ROA(3y)1.79%
ROA(5y)2.56%
ROE(3y)2.5%
ROE(5y)3.16%
ROIC(3y)2.97%
ROIC(5y)N/A
1.3 Margins
With an excellent Profit Margin value of 11.70%, KMDA belongs to the best of the industry, outperforming 91.70% of the companies in the same industry.
In the last couple of years the Profit Margin of KMDA has declined.
With an excellent Operating Margin value of 15.89%, KMDA belongs to the best of the industry, outperforming 93.58% of the companies in the same industry.
In the last couple of years the Operating Margin of KMDA has declined.
With a decent Gross Margin value of 43.75%, KMDA is doing good in the industry, outperforming 74.53% of the companies in the same industry.
KMDA's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.89% | ||
| PM (TTM) | 11.7% | ||
| GM | 43.75% |
OM growth 3YN/A
OM growth 5Y-7.07%
PM growth 3YN/A
PM growth 5Y-13.08%
GM growth 3Y14.12%
GM growth 5Y2.16%
2. Health
2.1 Basic Checks
KMDA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
KMDA has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, KMDA has more shares outstanding
KMDA has a worse debt/assets ratio than last year.
2.2 Solvency
KMDA has an Altman-Z score of 3.29. This indicates that KMDA is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.29, KMDA is doing good in the industry, outperforming 69.25% of the companies in the same industry.
KMDA has a debt to FCF ratio of 0.59. This is a very positive value and a sign of high solvency as it would only need 0.59 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.59, KMDA belongs to the best of the industry, outperforming 95.09% of the companies in the same industry.
KMDA has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
KMDA has a Debt to Equity ratio (0.04) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 0.59 | ||
| Altman-Z | 3.29 |
ROIC/WACC0.78
WACC8.51%
2.3 Liquidity
KMDA has a Current Ratio of 4.02. This indicates that KMDA is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 4.02, KMDA is in line with its industry, outperforming 48.11% of the companies in the same industry.
A Quick Ratio of 2.25 indicates that KMDA has no problem at all paying its short term obligations.
KMDA's Quick ratio of 2.25 is on the low side compared to the rest of the industry. KMDA is outperformed by 71.32% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.02 | ||
| Quick Ratio | 2.25 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 28.57% over the past year.
The earnings per share for KMDA have been decreasing by -13.60% on average. This is quite bad
The Revenue has grown by 10.36% in the past year. This is quite good.
KMDA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.82% yearly.
EPS 1Y (TTM)28.57%
EPS 3YN/A
EPS 5Y-13.6%
EPS Q2Q%28.57%
Revenue 1Y (TTM)10.36%
Revenue growth 3Y15.82%
Revenue growth 5Y4.82%
Sales Q2Q%12.63%
3.2 Future
Based on estimates for the next years, KMDA will show a very strong growth in Earnings Per Share. The EPS will grow by 29.48% on average per year.
Based on estimates for the next years, KMDA will show a quite strong growth in Revenue. The Revenue will grow by 10.31% on average per year.
EPS Next Y44.17%
EPS Next 2Y31.88%
EPS Next 3Y29.48%
EPS Next 5YN/A
Revenue Next Year12.37%
Revenue Next 2Y11.55%
Revenue Next 3Y10.31%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 19.58 indicates a rather expensive valuation of KMDA.
Based on the Price/Earnings ratio, KMDA is valued cheaply inside the industry as 94.34% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 26.84, KMDA is valued a bit cheaper.
Based on the Price/Forward Earnings ratio of 15.59, the valuation of KMDA can be described as correct.
Compared to the rest of the industry, the Price/Forward Earnings ratio of KMDA indicates a rather cheap valuation: KMDA is cheaper than 95.85% of the companies listed in the same industry.
KMDA's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.40.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.58 | ||
| Fwd PE | 15.59 |
4.2 Price Multiples
97.36% of the companies in the same industry are more expensive than KMDA, based on the Enterprise Value to EBITDA ratio.
KMDA's Price/Free Cash Flow ratio is rather cheap when compared to the industry. KMDA is cheaper than 95.09% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.69 | ||
| EV/EBITDA | 8.04 |
4.3 Compensation for Growth
KMDA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of KMDA may justify a higher PE ratio.
KMDA's earnings are expected to grow with 29.48% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.44
PEG (5Y)N/A
EPS Next 2Y31.88%
EPS Next 3Y29.48%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.83%, KMDA has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 1.05, KMDA pays a better dividend. On top of this KMDA pays more dividend than 98.68% of the companies listed in the same industry.
KMDA's Dividend Yield is a higher than the S&P500 average which is at 2.00.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.83% |
5.2 History
KMDA is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y31.88%
EPS Next 3Y29.48%
7.05
-0.02 (-0.28%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners11.39%
Inst Owner Change3.21%
Ins Owners2.34%
Ins Owner ChangeN/A
Market Cap406.64M
Revenue(TTM)174.79M
Net Income(TTM)20.45M
Analysts84.44
Price Target13.26 (88.09%)
Short Float %0.14%
Short Ratio0.52
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.83% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)20.52%
Min EPS beat(2)-4.61%
Max EPS beat(2)45.66%
EPS beat(4)3
Avg EPS beat(4)17.85%
Min EPS beat(4)-4.61%
Max EPS beat(4)45.66%
EPS beat(8)6
Avg EPS beat(8)19.32%
EPS beat(12)9
Avg EPS beat(12)7.95%
EPS beat(16)10
Avg EPS beat(16)-82.64%
Revenue beat(2)1
Avg Revenue beat(2)-0.44%
Min Revenue beat(2)-1.49%
Max Revenue beat(2)0.61%
Revenue beat(4)2
Avg Revenue beat(4)-0.44%
Min Revenue beat(4)-3.06%
Max Revenue beat(4)2.19%
Revenue beat(8)3
Avg Revenue beat(8)-0.6%
Revenue beat(12)4
Avg Revenue beat(12)-0.9%
Revenue beat(16)6
Avg Revenue beat(16)1.07%
PT rev (1m)-11.86%
PT rev (3m)-18.75%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-22.5%
EPS NY rev (1m)-3.92%
EPS NY rev (3m)-3.92%
Revenue NQ rev (1m)-0.38%
Revenue NQ rev (3m)-1.28%
Revenue NY rev (1m)0.27%
Revenue NY rev (3m)0.27%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.58 | ||
| Fwd PE | 15.59 | ||
| P/S | 2.33 | ||
| P/FCF | 21.69 | ||
| P/OCF | 14.02 | ||
| P/B | 1.53 | ||
| P/tB | 1.73 | ||
| EV/EBITDA | 8.04 |
EPS(TTM)0.36
EY5.11%
EPS(NY)0.45
Fwd EY6.41%
FCF(TTM)0.33
FCFY4.61%
OCF(TTM)0.5
OCFY7.13%
SpS3.03
BVpS4.59
TBVpS4.07
PEG (NY)0.44
PEG (5Y)N/A
Graham Number6.1
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.42% | ||
| ROE | 7.72% | ||
| ROCE | 8.44% | ||
| ROIC | 6.67% | ||
| ROICexc | 8.54% | ||
| ROICexgc | 9.66% | ||
| OM | 15.89% | ||
| PM (TTM) | 11.7% | ||
| GM | 43.75% | ||
| FCFM | 10.73% |
ROA(3y)1.79%
ROA(5y)2.56%
ROE(3y)2.5%
ROE(5y)3.16%
ROIC(3y)2.97%
ROIC(5y)N/A
ROICexc(3y)3.77%
ROICexc(5y)N/A
ROICexgc(3y)8.9%
ROICexgc(5y)N/A
ROCE(3y)3.76%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-12.21%
ROICexc growth 3YN/A
ROICexc growth 5Y-24.77%
OM growth 3YN/A
OM growth 5Y-7.07%
PM growth 3YN/A
PM growth 5Y-13.08%
GM growth 3Y14.12%
GM growth 5Y2.16%
F-Score7
Asset Turnover0.46
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.04 | ||
| Debt/FCF | 0.59 | ||
| Debt/EBITDA | 0.22 | ||
| Cap/Depr | 67.04% | ||
| Cap/Sales | 5.86% | ||
| Interest Coverage | 35.6 | ||
| Cash Conversion | 67.35% | ||
| Profit Quality | 91.69% | ||
| Current Ratio | 4.02 | ||
| Quick Ratio | 2.25 | ||
| Altman-Z | 3.29 |
F-Score7
WACC8.51%
ROIC/WACC0.78
Cap/Depr(3y)51.55%
Cap/Depr(5y)66.64%
Cap/Sales(3y)4.62%
Cap/Sales(5y)4.32%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)28.57%
EPS 3YN/A
EPS 5Y-13.6%
EPS Q2Q%28.57%
EPS Next Y44.17%
EPS Next 2Y31.88%
EPS Next 3Y29.48%
EPS Next 5YN/A
Revenue 1Y (TTM)10.36%
Revenue growth 3Y15.82%
Revenue growth 5Y4.82%
Sales Q2Q%12.63%
Revenue Next Year12.37%
Revenue Next 2Y11.55%
Revenue Next 3Y10.31%
Revenue Next 5YN/A
EBIT growth 1Y56.49%
EBIT growth 3YN/A
EBIT growth 5Y-2.59%
EBIT Next Year134.37%
EBIT Next 3Y44.92%
EBIT Next 5YN/A
FCF growth 1Y941.67%
FCF growth 3YN/A
FCF growth 5Y7.92%
OCF growth 1Y336.09%
OCF growth 3YN/A
OCF growth 5Y11.73%
KAMADA LTD / KMDA FAQ
Can you provide the ChartMill fundamental rating for KAMADA LTD?
ChartMill assigns a fundamental rating of 6 / 10 to KMDA.
Can you provide the valuation status for KAMADA LTD?
ChartMill assigns a valuation rating of 8 / 10 to KAMADA LTD (KMDA). This can be considered as Undervalued.
Can you provide the profitability details for KAMADA LTD?
KAMADA LTD (KMDA) has a profitability rating of 7 / 10.
Can you provide the financial health for KMDA stock?
The financial health rating of KAMADA LTD (KMDA) is 6 / 10.
Can you provide the expected EPS growth for KMDA stock?
The Earnings per Share (EPS) of KAMADA LTD (KMDA) is expected to grow by 44.17% in the next year.